目次

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Product
1.2.2. Type
1.2.3. End Use
1.2.4. Regional scope
1.2.5. Estimates and forecasts timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. GVR’s internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.4.5. Details of primary research
1.4.5.1. Data for primary interviews in North America
1.4.5.2. Data for primary interviews in Europe
1.4.5.3. Data for primary interviews in Asia Pacific
1.4.5.4. Data for primary interviews in Latin America
1.4.5.5. Data for Primary interviews in MEA
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.2. Approach 1: Commodity flow approach
1.7.3. Volume price analysis (Model 2)
1.7.4. Approach 2: Volume price analysis
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives

Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Product outlook
2.2.2. Type outlook
2.2.3. End Use outlook
2.2.4. Regional outlook
2.3. Competitive Insights

Chapter 3. Shingles Vaccine Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Increasing risk of developing shingles
3.2.1.2. Increase in recommendation of shingles vaccine
3.2.1.3. Cost - effectiveness of shingles vaccine
3.2.2. Market restraint analysis
3.2.2.1. Low awareness regarding shingles
3.2.2.2. Weak product pipeline
3.3. Shingles Vaccine Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Technological landscape
3.3.2.3. Economic landscape
3.3.3. Pipeline Analysis

Chapter 4. Shingles Vaccine Market: Product Estimates & Trend Analysis
4.1. Global Shingles Vaccine Market: Product Dashboard
4.2. Global Shingles Vaccine Market: Product Movement Analysis
4.3. Global Shingles Vaccine Market by Product, Revenue
4.4. Shingrix
4.4.1. Shingrix market estimates and forecasts 2018 to 2030 (USD Million)
4.5. Zostavax
4.5.1. Zostavax market estimates and forecasts 2018 to 2030 (USD Million)
4.6. SKYZoster
4.6.1. SKYZoster market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Shingles Vaccine Market: Type Estimates & Trend Analysis
5.1. Global Shingles Vaccine Market: Type Dashboard
5.2. Global Shingles Vaccine Market: Type Movement Analysis
5.3. Global Shingles Vaccine Market Estimates and Forecasts, By Type, Revenue (USD Million)
5.4. Recombinant Vaccine
5.4.1. Recombinant Vaccine market estimates and forecasts 2018 to 2030 (USD Million)
5.5. Live Attenuated Vaccine
5.5.1. Live Attenuated Vaccine market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Shingles Vaccine Market: End Use Estimates & Trend Analysis
6.1. Global Shingles Vaccine Market: End Use Dashboard
6.2. Global Shingles Vaccine Market: End Use Movement Analysis
6.3. Global Shingles Vaccine Market Estimates and Forecasts, by End Use, Revenue (USD Million)
6.4. Private Healthcare Settings
6.4.1. Private Healthcare Settings market estimates and forecasts 2018 to 2030 (USD Million)
6.5. Government Healthcare Settings
6.5.1. Government Healthcare Settings market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Shingles Vaccine Market: Regional Estimates & Trend Analysis by Product, Type, End Use
7.1. Regional Dashboard
7.2. Market Size, & Forecasts Trend Analysis, 2018 to 2030
7.3. North America
7.3.1. U.S.
7.3.1.1. Key country dynamics
7.3.1.2. Regulatory framework/ reimbursement structure
7.3.1.3. Competitive scenario
7.3.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
7.3.2. Canada
7.3.2.1. Key country dynamics
7.3.2.2. Regulatory framework/ reimbursement structure
7.3.2.3. Competitive scenario
7.3.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
7.3.3. Mexico
7.3.3.1. Key country dynamics
7.3.3.2. Regulatory framework/ reimbursement structure
7.3.3.3. Competitive scenario
7.3.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
7.4. Europe
7.4.1. UK
7.4.1.1. Key country dynamics
7.4.1.2. Regulatory framework/ reimbursement structure
7.4.1.3. Competitive scenario
7.4.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
7.4.2. Germany
7.4.2.1. Key country dynamics
7.4.2.2. Regulatory framework/ reimbursement structure
7.4.2.3. Competitive scenario
7.4.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
7.4.3. France
7.4.3.1. Key country dynamics
7.4.3.2. Regulatory framework/ reimbursement structure
7.4.3.3. Competitive scenario
7.4.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
7.4.4. Italy
7.4.4.1. Key country dynamics
7.4.4.2. Regulatory framework/ reimbursement structure
7.4.4.3. Competitive scenario
7.4.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
7.4.5. Spain
7.4.5.1. Key country dynamics
7.4.5.2. Regulatory framework/ reimbursement structure
7.4.5.3. Competitive scenario
7.4.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
7.4.6. Norway
7.4.6.1. Key country dynamics
7.4.6.2. Regulatory framework/ reimbursement structure
7.4.6.3. Competitive scenario
7.4.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
7.4.7. Sweden
7.4.7.1. Key country dynamics
7.4.7.2. Regulatory framework/ reimbursement structure
7.4.7.3. Competitive scenario
7.4.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
7.4.8. Denmark
7.4.8.1. Key country dynamics
7.4.8.2. Regulatory framework/ reimbursement structure
7.4.8.3. Competitive scenario
7.4.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
7.5. Asia Pacific
7.5.1. Japan
7.5.1.1. Key country dynamics
7.5.1.2. Regulatory framework/ reimbursement structure
7.5.1.3. Competitive scenario
7.5.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
7.5.2. China
7.5.2.1. Key country dynamics
7.5.2.2. Regulatory framework/ reimbursement structure
7.5.2.3. Competitive scenario
7.5.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
7.5.3. India
7.5.3.1. Key country dynamics
7.5.3.2. Regulatory framework/ reimbursement structure
7.5.3.3. Competitive scenario
7.5.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
7.5.4. Australia
7.5.4.1. Key country dynamics
7.5.4.2. Regulatory framework/ reimbursement structure
7.5.4.3. Competitive scenario
7.5.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
7.5.5. South Korea
7.5.5.1. Key country dynamics
7.5.5.2. Regulatory framework/ reimbursement structure
7.5.5.3. Competitive scenario
7.5.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
7.5.6. Thailand
7.5.6.1. Key country dynamics
7.5.6.2. Regulatory framework/ reimbursement structure
7.5.6.3. Competitive scenario
7.5.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
7.6. Latin America
7.6.1. Brazil
7.6.1.1. Key country dynamics
7.6.1.2. Regulatory framework/ reimbursement structure
7.6.1.3. Competitive scenario
7.6.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
7.6.2. Argentina
7.6.2.1. Key country dynamics
7.6.2.2. Regulatory framework/ reimbursement structure
7.6.2.3. Competitive scenario
7.6.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
7.7. MEA
7.7.1. South Africa
7.7.1.1. Key country dynamics
7.7.1.2. Regulatory framework/ reimbursement structure
7.7.1.3. Competitive scenario
7.7.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
7.7.2. Saudi Arabia
7.7.2.1. Key country dynamics
7.7.2.2. Regulatory framework/ reimbursement structure
7.7.2.3. Competitive scenario
7.7.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
7.7.3. UAE
7.7.3.1. Key country dynamics
7.7.3.2. Regulatory framework/ reimbursement structure
7.7.3.3. Competitive scenario
7.7.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
7.7.4. Kuwait
7.7.4.1. Key country dynamics
7.7.4.2. Regulatory framework/ reimbursement structure
7.7.4.3. Competitive scenario
7.7.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Competitive Landscape
8.1. Company/Competition Categorization
8.2. Vendor Landscape
8.2.1. List of key distributors and channel partners
8.2.2. Key customers
8.2.3. Key company market share analysis, 2023
8.2.4. GlaxoSmithKline plc.
8.2.4.1. Company overview
8.2.4.2. Financial performance
8.2.4.3. Product benchmarking
8.2.4.4. Strategic initiatives
8.2.5. Merck & Co., Inc.
8.2.5.1. Company overview
8.2.5.2. Financial performance
8.2.5.3. Product benchmarking
8.2.5.4. Strategic initiatives
8.2.6. SK chemicals
8.2.6.1. Company overview
8.2.6.2. Financial performance
8.2.6.3. Product benchmarking
8.2.6.4. Strategic initiatives
8.2.7. Green Cross Corp
8.2.7.1. Company overview
8.2.7.2. Financial performance
8.2.7.3. Product benchmarking
8.2.7.4. Strategic initiatives
8.2.8. Geneone Life Science
8.2.8.1. Company overview
8.2.8.2. Financial performance
8.2.8.3. Product benchmarking
8.2.8.4. Strategic initiatives
8.2.9. Vaccitech
8.2.9.1. Company overview
8.2.9.2. Financial performance
8.2.9.3. Product benchmarking
8.2.9.4. Strategic initiatives
8.2.10. CanSinoBIO
8.2.10.1. Company overview
8.2.10.2. Financial performance
8.2.10.3. Product benchmarking
8.2.10.4. Strategic initiatives

List of Tables
Table 1 List of abbreviation
Table 2 North America Shingles vaccine market, by region, 2018 - 2030 (USD Million)
Table 3 North America shingles vaccine market, by product, 2018 - 2030 (USD Million)
Table 4 North America shingles vaccine market, by type, 2018 - 2030 (USD Million)
Table 5 U.S. shingles vaccine market, by product, 2018 - 2030 (USD Million)
Table 6 U.S. shingles vaccine market, by type, 2018 - 2030 (USD Million)
Table 7 U.S. shingles vaccine market, by end use, 2018 - 2030 (USD Million)
Table 8 Canada shingles vaccine market, by product, 2018 - 2030 (USD Million)
Table 9 Canada shingles vaccine market, by type, 2018 - 2030 (USD Million)
Table 10 Canada shingles vaccine market, by end use, 2018 - 2030 (USD Million)
Table 11 Mexico shingles vaccine market, by product, 2018 - 2030 (USD Million)
Table 12 Mexico shingles vaccine market, by type, 2018 - 2030 (USD Million)
Table 13 Mexico shingles vaccine market, by end use, 2018 - 2030 (USD Million)
Table 14 Europe shingles vaccine market, by region, 2018 - 2030 (USD Million)
Table 15 Europe shingles vaccine market, byproduct, 2018 - 2030 (USD Million)
Table 16 Europe shingles vaccine market, by type, 2018 - 2030 (USD Million)
Table 17 Europe shingles vaccine market, by end use, 2018 - 2030 (USD Million)
Table 18 Germany shingles vaccine market, by product, 2018 - 2030 (USD Million)
Table 19 Germany shingles vaccine market, by type, 2018 - 2030 (USD Million)
Table 20 Germany shingles vaccine market, by end use, 2018 - 2030 (USD Million)
Table 21 UK shingles vaccine market, by product, 2018 - 2030 (USD Million)
Table 22 UK shingles vaccine market, by type, 2018 - 2030 (USD Million)
Table 23 UK shingles vaccine market, by end use, 2018 - 2030 (USD Million)
Table 24 France shingles vaccine market, by product, 2018 - 2030 (USD Million)
Table 25 France shingles vaccine market, by type, 2018 - 2030 (USD Million)
Table 26 France shingles vaccine market, by end use, 2018 - 2030 (USD Million)
Table 27 Italy shingles vaccine market, by product, 2018 - 2030 (USD Million)
Table 28 Italy shingles vaccine market, by type, 2018 - 2030 (USD Million)
Table 29 Italy shingles vaccine market, by end use, 2018 - 2030 (USD Million)
Table 30 Spain shingles vaccine market, by product, 2018 - 2030 (USD Million)
Table 31 Spain shingles vaccine market, by type, 2018 - 2030 (USD Million)
Table 32 Spain shingles vaccine market, by end use, 2018 - 2030 (USD Million)
Table 33 Denmark shingles vaccine market, by product, 2018 - 2030 (USD Million)
Table 34 Denmark shingles vaccine market, by type, 2018 - 2030 (USD Million)
Table 35 Denmark shingles vaccine market, by end use, 2018 - 2030 (USD Million)
Table 36 Sweden shingles vaccine market, by product, 2018 - 2030 (USD Million)
Table 37 Sweden shingles vaccine market, by type, 2018 - 2030 (USD Million)
Table 38 Sweden shingles vaccine market, by end use, 2018 - 2030 (USD Million)
Table 39 Norway shingles vaccine market, by product, 2018 - 2030 (USD Million)
Table 40 Norway shingles vaccine market, by type, 2018 - 2030 (USD Million)
Table 41 Norway shingles vaccine market, by end use, 2018 - 2030 (USD Million)
Table 42 Asia Pacific shingles vaccine market, by region, 2018 - 2030 (USD Million)
Table 43 Asia Pacific shingles vaccine market, by product, 2018 - 2030 (USD Million)
Table 44 Asia Pacific shingles vaccine market, by type, 2018 - 2030 (USD Million)
Table 45 Aisa Pacific shingles vaccine market, by end use, 2018 - 2030 (USD Million)
Table 46 China shingles vaccine market, by product, 2018 - 2030 (USD Million)
Table 47 China shingles vaccine market, by type, 2018 - 2030 (USD Million)
Table 48 China shingles vaccine market, by end use, 2018 - 2030 (USD Million)
Table 49 Japan shingles vaccine market, byproduct, 2018 - 2030 (USD Million)
Table 50 Japan shingles vaccine market, by type, 2018 - 2030 (USD Million)
Table 51 Japan shingles vaccine market, by end use, 2018 - 2030 (USD Million)
Table 52 India shingles vaccine market, by product, 2018 - 2030 (USD Million)
Table 53 India shingles vaccine market, by type, 2018 - 2030 (USD Million)
Table 54 India shingles vaccine market, by end use, 2018 - 2030 (USD Million)
Table 55 South Korea shingles vaccine market, by product, 2018 - 2030 (USD Million)
Table 56 South Korea shingles vaccine market, by type, 2018 - 2030 (USD Million)
Table 57 South Korea shingles vaccine market, by end use, 2018 - 2030 (USD Million)
Table 58 Australia shingles vaccine market, by product, 2018 - 2030 (USD Million)
Table 59 Australia shingles vaccine market, by type, 2018 - 2030 (USD Million)
Table 60 Australia shingles vaccine market, by end use, 2018 - 2030 (USD Million)
Table 61 Thailand shingles vaccine market, by product, 2018 - 2030 (USD Million)
Table 62 Thailand shingles vaccine market, by type, 2018 - 2030 (USD Million)
Table 63 Thailand shingles vaccine market, by end use, 2018 - 2030 (USD Million)
Table 64 Latin America shingles vaccine market, by region, 2018 - 2030 (USD Million)
Table 65 Latin America shingles vaccine market, by product, 2018 - 2030 (USD Million)
Table 66 Latin America shingles vaccine market, by type, 2018 - 2030 (USD Million)
Table 67 Latin America shingles vaccine market, by end use, 2018 - 2030 (USD Million)
Table 68 Brazil shingles vaccine market, by product, 2018 - 2030 (USD Million)
Table 69 Brazil shingles vaccine market, by vaccine product, 2018 - 2030 (USD Million)
Table 70 Brazil shingles vaccine market, by end use, 2018 - 2030 (USD Million)
Table 71 Argentina shingles vaccine market, by type, 2018 - 2030 (USD Million)
Table 72 Argentina shingles vaccine market, by type, 2018 - 2030 (USD Million)
Table 73 Argentina shingles vaccine market, by end use, 2018 - 2030 (USD Million)
Table 74 MEA shingles vaccine market, by region, 2018 - 2030 (USD Million)
Table 75 MEA shingles vaccine market, by product, 2018 - 2030 (USD Million)
Table 76 MEA shingles vaccine market, by type, 2018 - 2030 (USD Million)
Table 77 MEA shingles vaccine market, by end use, 2018 - 2030 (USD Million)
Table 78 South Africa shingles vaccine market, by product, 2018 - 2030 (USD Million)
Table 79 South Africa shingles vaccine market, by type, 2018 - 2030 (USD Million)
Table 80 South Africa shingles vaccine market, by end use, 2018 - 2030 (USD Million)
Table 81 Saudi Arabia shingles vaccine market, by product, 2018 - 2030 (USD Million)
Table 82 Saudi Arabia shingles vaccine market, by type, 2018 - 2030 (USD Million)
Table 83 Saudi Arabia shingles vaccine market, by end use, 2018 - 2030 (USD Million)
Table 84 UAE shingles vaccine market, by product, 2018 - 2030 (USD Million)
Table 85 UAE shingles vaccine market, by type, 2018 - 2030 (USD Million)
Table 86 UAE shingles vaccine market, by end use, 2018 - 2030 (USD Million)
Table 87 Kuwait shingles vaccine market, by product, 2018 - 2030 (USD Million)
Table 88 Kuwait shingles vaccine market, by type, 2018 - 2030 (USD Million)
Table 89 Kuwait shingles vaccine market, by end use, 2018 - 2030 (USD Million)

List of Figures
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Primary interviews in North America
Fig. 5 Primary interviews in Europe
Fig. 6 Primary interviews in APAC
Fig. 7 Primary interviews in Latin America
Fig. 8 Primary interviews in MEA
Fig. 9 Market research approaches
Fig. 10 Value-chain-based sizing & forecasting
Fig. 11 QFD modeling for market share assessment
Fig. 12 Market formulation & validation
Fig. 13 Shingles vaccine market: market outlook
Fig. 14 Shingles vaccine market competitive insights
Fig. 15 Parent market outlook
Fig. 16 Related/ancillary market outlook
Fig. 17 Shingles vaccine market driver impact
Fig. 18 Shingles vaccine market restraint impact
Fig. 19 Shingles vaccine market: Product movement analysis
Fig. 20 Shingles vaccine market: Product outlook and key takeaways
Fig. 21 Shingrix market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 22 Zostavax market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 23 SKYZoster market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 24 Shingles vaccine market: Vaccine type movement analysis
Fig. 25 Shingles vaccine market: Vaccine type outlook and key takeaways
Fig. 26 Recombinant Vaccine market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 27 Live Attenuated Vaccine market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 28 Shingles vaccine market: End Use movement analysis
Fig. 29 Shingles vaccine market: End Use outlook and key takeaways
Fig. 30 Private Healthcare Settings market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 31 Government Healthcare Settings market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 32 Global Shingles vaccine market: Regional movement analysis
Fig. 33 Global Shingles vaccine market: Regional outlook and key takeaways
Fig. 34 Global Shingles vaccine market share and leading players
Fig. 35 North America, by country
Fig. 36 North America market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 37 U.S. key country dynamics
Fig. 38 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 39 Canada key country dynamics
Fig. 40 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 41 Mexico key country dynamics
Fig. 42 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 43 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 44 UK key country dynamics
Fig. 45 UK market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 46 Germany key country dynamics
Fig. 47 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 48 France key country dynamics
Fig. 49 France market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 50 Italy key country dynamics
Fig. 51 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 52 Spain key country dynamics
Fig. 53 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 54 Denmark key country dynamics
Fig. 55 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 56 Sweden key country dynamics
Fig. 57 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 58 Norway key country dynamics
Fig. 59 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 60 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 61 China key country dynamics
Fig. 62 China market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 63 Japan key country dynamics
Fig. 64 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 65 India key country dynamics
Fig. 66 India market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 67 Thailand key country dynamics
Fig. 68 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 69 South Korea key country dynamics
Fig. 70 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 71 Australia key country dynamics
Fig. 72 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 73 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 74 Brazil key country dynamics
Fig. 75 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 76 Argentina key country dynamics
Fig. 77 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 78 Middle East and Africa market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 79 South Africa key country dynamics
Fig. 80 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 81 Saudi Arabia key country dynamics
Fig. 82 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 83 UAE key country dynamics
Fig. 84 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 85 Kuwait key country dynamics
Fig. 86 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 87 Market share of key market players- Shingles vaccine market